Collecting plasma and white blood cells for research on HIV and immune health
Collects blood plasma and white cells from healthy adults and people with HIV.
Key facts
- Who runs it
- National Institute of Allergy and Infectious Diseases (NIAID)
- Where
- Bethesda, United StatesSee the site
- Trial code
- Registry title
- Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies
- Status
- Recruiting
- People taking part
- 3,000 people, planned
- Started
- 9 Jan 1984
- Type of study
- Observational, 2 groups
- Record updated
- 16 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults to give blood plasma and white blood cells by apheresis for laboratory research. NIH patients, their relatives and healthy volunteers can join.
- Age
- 18 years or older (up to 100 years)
- Sex
- All sexes
Main reasons for not taking part
- Pregnant or breast-feeding women
- Currently abusing alcohol or other drugs
- Blood counts too low for apheresis
- Any medical condition for which the study doctor thinks apheresis or other sample collection might be unsafe
The registry criteria, word for word
Show all 4 criteriaShow less
Who cannot take part
- Currently abusing alcohol or other drugs
- Any medical condition for which the PI feels apheresis or other sample collection procedures might be contraindicated
- Pregnant and/or breast-feeding women
Other criteria
- INCLUSION CRITERIA:; 18 years of age or older; Adequate venous access; Blood pressure less than or equal to 180/100; pulse rate 50-100, unless a lower pulse rate is considered normal for the volunteer (e.g. a conditioned athlete); Adequate blood counts if undergoing apheresis (HIV positive volunteers and volunteers with vasculitis or other inflammatory diseases: hemoglobin greater than or equal to 9.0 g/dL, HCT greater than or equal to 28%, platelets greater than or equal to 50,000; HIV negative volunteers: hemoglobin greater than or equal to 12.5 g/dL, HCT greater than or equal to 38%, platelets greater than or equal to 150,000); Willing and able to provide written informed consent, comply with study requirements and procedures, and comply with clinic policies (including stored samples, hepatitis screening, and genetic testing including HLA testing)
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Where in United States
- National Institutes of Health Clinical CenterBethesda, United StatesContact: Holly A Baus, R.N.Taking people
About the trial
What the trial wants to find out
This study will collect blood plasma and white blood cells from individuals using a procedure called apheresis. Apheresis is a method of collecting larger quantities of certain blood components that can safely be collected through a simple blood draw. The blood components will be used in laboratory research studies.
Read full original descriptionShow less
Patients 18 years of age and older who are currently enrolled in a NIH clinical research protocol may participate in this study. Relatives of patients and normal healthy volunteers will also be enrolled.
Individuals will undergo one of the following two apheresis procedures:
* Automated pheresis Blood is drawn through a needle placed in an arm vein and circulated through a cell separator machine. The plasma (liquid part of the blood) and white cells are extracted, and the red cells are re-infused into the donor through the same needle or a needle in the other arm. An anticoagulant (medication to prevent blood from clotting) is usually added to the blood while in the machine to prevent it from clotting during processing. * Manual pheresis One unit (1 pint) of blood is drawn through a needle placed in an arm vein, similar to donating a pint of whole blood. The red blood cells, with or without plasma, are separated from the rest of the blood and returned to the donor through the same needle. Manual pheresis will be done only when a person s estimated total blood volume or red cell count is too low to safely permit removal of blood through a pheresis machine. An adult small in size or markedly anemic, for example, may fall into this category.
Some of the blood collected through apheresis may be stored for future studies of HIV disease and immune function and for HLA testing, a genetic test of markers of the immune system. Some of the blood may be used to screen for different types of viral liver infections, such as hepatitis A, B, C, D, E, F, or G.
The 2 groups in the trial
- 1
Healthy Volunteers
- 2
HIV
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Procedures to Obtain Plasma, Lymphocytes, or Other Specimens for Research Studies
- Plain-language title
- Collecting plasma and white blood cells for research on HIV and immune healthGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Criteria questions
- Built from NCT00114647, who can take part
- Record updated
- 16 September 2026